All News

Plaquenil.HCQ_.pills_.jpg (keep)

Best of 2020: The Nine Lives of Hydroxychloroquine (Updated)

d Martin J. Bergman, MD

Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory arthropathy.

Read Article
podcast logo

RheumNow Podcast – Up, Down & Turned Around (12.18.20)

d Jack Cush, MD

Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Read Article
vaccine.jpg

ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)

d CDC/MMWR

Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years. 

Read Article
fellows.RWCS_.JPG

Encouraging Rheumatology Fellowship Match for 2021

d JJ Cush and ACR Press Release

The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.

Read Article
FDA issues emergency use authorization (EUA) for the 2nd COVID-19 vaccine from MODERNA. “With the availability of 2 vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic..." https://t.co/AnmwOZtALk

Links:

Dr. John Cush RheumNow ( View Tweet)

Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth examines the cardiovascular safety in the FAST trial of Feboxustat at #ACR20. https://t.co/XCdtWpLKWR https://t.co/BLQdK6tq2s

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast is up! Up, Down & Turned Around - Advice on COVID Vaccines, Belimumab in lupus nephritis, and good news for Rheum Fellowships. Watch it here> https://t.co/n4PQKVfHlb or listen to podcast on iTunes https://t.co/FHJv01AAbC or SoundCloud https://t.co/y78tp4yWI1 https://t.co/RDVN9AvOdj

Links:

Dr. John Cush RheumNow ( View Tweet)
Year in Review: Wisdom for New Rheumatology Fellows https://t.co/dcg0kdLhfD https://t.co/AOw1PkVVNT

Links:

Dr. John Cush RheumNow ( View Tweet)
ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations) https://t.co/Q15gQRWGhg https://t.co/Jk1PbRzMtT

Links:

Dr. John Cush RheumNow ( View Tweet)
Check out the RheumNow podcast on Soundcloud and Apple/Android devices. This weeks--Up, Down & Turned Around. We review the news and journal articles from the last week on the site. https://t.co/n4PQKVfHlb https://t.co/HXr4I21Vzk

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatology Roundup #ACR20 https://t.co/uov1DwNxsn https://t.co/DDF4mzfPwr

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast up! COVID Vaccine Q & A - Dr Kevin Winthrop https://t.co/EJL6hVLnrp https://t.co/3oriO09PBU

Links:

Dr. John Cush RheumNow ( View Tweet)
New ACR RA Guidelines and Practice Changing Abstracts: Panel Panelists include Dr.Kathryn Dao ( @KDAO2011), Dr. Eric Dein ( @ejdein1), Dr. Meral El Ramahi ( @MeralElRamahiMD), Dr. Richard Conway ( @RichardPAConway) + Dr. Sheila Reyes( @RHEUMarampa) #ACR20 https://t.co/WEgQpwUlC6 https://t.co/zFiXtzsHGB

Links:

Dr. John Cush RheumNow ( View Tweet)
COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? Dr. Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last. #ACR20 https://t.co/KWq5ey5Kcf https://t.co/QKFZVnrMpD

Links:

Dr. John Cush RheumNow ( View Tweet)
Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay offers his view of an important question for a large group of RA patients. #acr20 https://t.co/4TS9BI6fOK https://t.co/FZFvsIpcHA

Links:

Dr. John Cush RheumNow ( View Tweet)
Encouraging Rheumatology Fellowship Match for 2021 https://t.co/DwAs47pgi5 https://t.co/Dl27nI3QlE

Links:

Dr. John Cush RheumNow ( View Tweet)
Panelists Dr. David Liew, Dr. Laura Cappelli, Dr. Cassandra Calabrese and Dr. Karmela Kim Chan discuss iRAE sessions and studies. #ACR20 https://t.co/3FpAGsSo9m https://t.co/r2qO5tYxR4

Links:

Dr. John Cush RheumNow ( View Tweet)
COVID-19–related mortality rates has become a leading cause of death according to statistics from the Centers for Disease Control and Prevention. Read more here https://t.co/KhrbLce2Q1 https://t.co/fQQ0suzA2A

Links:

Dr. John Cush RheumNow ( View Tweet)
How FAST can you go? with Dr. Michael Pillinger #acr20 https://t.co/YV2lyAAEyY https://t.co/bycb4KHf9S

Links:

Dr. John Cush RheumNow ( View Tweet)
Benlysta First Agent Approved for Lupus Nephritis: GlaxoSmithKline announced yesterday that the FDA has approved belimumab (Benlysta) for use in adults with active lupus nephritis (LN) receiving background/standard therapy. https://t.co/O7CBAn55t2 https://t.co/RWNDzUqxhM

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×